Assessing the extent and timing of chemosensory impairments during COVID-19 pandemic
Abstract Chemosensory impairments have been established as a specific indicator of COVID-19. They affect most patients and may persist long past the resolution of respiratory symptoms, representing an unprecedented medical challenge. Since the SARS-CoV-2 pandemic started, we now know much more about...
Main Authors: | Cinzia Cecchetto, Antonella Di Pizio, Federica Genovese, Orietta Calcinoni, Alberto Macchi, Andreas Dunkel, Kathrin Ohla, Sara Spinelli, Michael C. Farruggia, Paule V. Joseph, Anna Menini, Elena Cantone, Caterina Dinnella, Maria Paola Cecchini, Anna D’Errico, Carla Mucignat-Caretta, Valentina Parma, Michele Dibattista |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-96987-0 |
Similar Items
-
TaSCA, an Agile Survey on Chemosensory Impairments for Self-Monitoring of COVID-19 Patients: A Pilot Study
by: Carla Mucignat-Caretta, et al.
Published: (2021-02-01) -
Beyond the Flavour: The Potential Druggability of Chemosensory G Protein-Coupled Receptors
by: Antonella Di Pizio, et al.
Published: (2019-03-01) -
Protein Kinase A Catalytic and Regulatory Subunits Interact Differently in Various Areas of Mouse Brain
by: Carla Mucignat-Caretta, et al.
Published: (2020-04-01) -
Protein Kinase A in Cancer
by: Antonio Caretta, et al.
Published: (2011-02-01) -
Tumors of the Central Nervous System: An Update
by: Carla Mucignat-Caretta
Published: (2020-09-01)